Minnich, Anne
Bristol-Myers Squibb (United States)
3 papers on CoChatORCID 0000-0001-5247-5276
Most cited papers
- Verified
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine
Cholesterol and Lipid MetabolismPeroxisome Proliferator-Activated Receptors
Cited by 1,170
- Verified
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)
Corte, T. J., Lancaster, L., Swigris, J. J., Maher, T. M., Goldin, J. G., Palmer, S. M., Suda, T., Ogura, T., Minnich, A., Zhan, X., et al. (2021) · BMJ Open Respiratory Research
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases
Cited by 59
- Verified
Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136–>His): association with mild dyslipidemia and double pre-beta very low density lipoproteins
Minnich, A., Weisgraber, K. H., Newhouse, Y., Dong, L. M., Fortin, L. J., Tremblay, M., & Davignon, J. (1995) · Journal of Lipid Research
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free